Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators

References

• Supuran CT. Carbonic anhydrase activators. Future Med Chem 2018;10:561–73.
   PubMed Web of Science ®Google Scholar
• Main RE, Locke A. Activation of carbonic anhydrase by histamine. J Biol Chem 1941;140:LXXXI.
   Google Scholar
• Clark AM, Perrin DD. A re-investigation of the question of activators of carbonic anhydrase. Biochem J 1951;48:495–503.
   PubMed Web of Science ®Google Scholar
• Tu CK, Silverman DN, Forsman C, et al. Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant. Biochemistry 1989;28:7913–18.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase activators. Part 4. A general mechanism of action for activators of isozymes I, II and III. Rev Roum Chim 1992;37:411–21.
   Web of Science ®Google Scholar
• Briganti F, Mangani S, Orioli P, et al. Carbonic anhydrase activators: x-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 1997;36:10384–92.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Balaban AT. Carbonic anhydrase activators. Part 8. pKa–activation relationship in a series of amino acid derivatives activators of isozyme II. Rev Roum Chim 1994;39:107–13.
   Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32. 
   PubMed Web of Science ®Google Scholar
  (c) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
   PubMed Web of Science ®Google Scholar
• Duda D, Tu C, Qian M, et al. Structural and kinetic analysis of the chemical rescue of the proton transfer function of carbonic anhydrase II. Biochemistry 2001;40:1741–8.
   PubMed Web of Science ®Google Scholar
• Duda D, Govindasamy L, Agbandje-McKenna M, et al. The refined atomic structure of carbonic anhydrase II at 1.05 A resolution: implications of chemical rescue of proton transfer. Acta Crystallogr D Biol Crystallogr 2003;59:93–104.
   PubMedGoogle Scholar
• Elder I, Tu C, Ming LJ, et al. Proton transfer from exogenous donors in catalysis by human carbonic anhydrase II. Arch Biochem Biophys 2005;437:106–14.
   PubMed Web of Science ®Google Scholar
• Shah GN, Bonapace G, Hu PY, et al. Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum Mutat 2004;24:272.
   PubMedGoogle Scholar
• Ogilvie JM, Ohlemiller KK, Shah GN, et al. Carbonic anhydrase XIV deficiency produces a functional defect in the retinal light response. Proc Natl Acad Sci USA 2007;104:8514–19.
   PubMed Web of Science ®Google Scholar
• Datta R, Shah GN, Rubbelke TS, et al. Progressive renal injury from transgenic expression of human carbonic anhydrase IV folding mutants is enhanced by deficiency of p58IPK. Proc Natl Acad Sci USA 2010;107:6448–52.
   PubMed Web of Science ®Google Scholar
• van Karnebeek CD, Sly WS, Ross CJ, et al. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood. Am J Hum Genet 2014;94:453–61.
   PubMed Web of Science ®Google Scholar
• Sun MK, Alkon DL. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol Sci 2002;23:83–9.
   PubMed Web of Science ®Google Scholar
• Sun MK, Alkon DL. Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther 2001;297:961–7.
   PubMed Web of Science ®Google Scholar
• Canto de Souza L, Provensi G, Vullo D, et al. Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. Neuropharmacology 2017;118:148–56.
   PubMed Web of Science ®Google Scholar
• Provensi G, Carta F, Nocentini A, et al. A new kid on the block? Carbonic anhydrases as possible new targets in Alzheimer’s disease. Int J Mol Sci 2019;20:4724.
   PubMed Web of Science ®Google Scholar
• Blandina P, Provensi G, Passsani MB, et al. Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders. J Enzyme Inhib Med Chem 2020;35:1206–14.
   PubMed Web of Science ®Google Scholar
• (a) Wang J, Ke T, Zhang X, et al. Effects of acetazolamide on cognitive performance during high-altitude exposure. Neurotoxicol Teratol 2013;35:28–33.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 2020;16:297–307. 
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT, Nicolae A, Popescu A. Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes. Eur J Med Chem 1996;31:431–8.
   Web of Science ®Google Scholar
• Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010;13:1161–9.
   PubMed Web of Science ®Google Scholar
• Schmidt SD, Costa A, Rani B, et al. The role of carbonic anhydrases in extinction of contextual fear memory. Proc Natl Acad Sci USA 2020;117:16000–8.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture. J Enzyme Inhib Med Chem 2013;28:229–30.
   PubMed Web of Science ®Google Scholar
  (b) De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117–29. 
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88.
   PubMed Web of Science ®Google Scholar
• Gentili D, Lapucci A, Macchia B, et al. Synthesis and beta-adrenergic activity of a series of 3-(substituted-benzylideneaminoxy)propanolamine derivatives. Farmaco 1995;50:519–26.
   PubMedGoogle Scholar
• Macchia B, Balsamo A, Lapucci A, et al. An interdisciplinary approach to the design of new structures active at the beta-adrenergic receptor. Aliphatic oxime ether derivatives. J Med Chem 1985;28:153–60.
   PubMed Web of Science ®Google Scholar
• Schenone S, Bruno O, Ranise A, et al. O-[2-hydroxy-3-(dialkylamino)propyl]ethers of (+)-1,7,7-trimethyl bicyclo[2.2.1]heptan-2-one oxime (camphor oxime) with analgesic and antiarrhythmic activities. Farmaco 2000;55:495–8.
   PubMedGoogle Scholar
• Krajewska M. Amino alkanol derivatives of oximes. Acta Polonia Pharmaceutica 1977;34:383–9.
   PubMedGoogle Scholar
• Martani A. New aromatic oxime ether derivatives with β-blocking activity. Farmaco 1975;30:370–9.
   Google Scholar
• Leclerc G, Mann A, Wermuth CG, et al. Synthesis and beta-adrenergic blocking activity of a novel class of aromatic oxime ethers. J Med Chem 1977;20:1657–62.
   PubMed Web of Science ®Google Scholar
• Leclerc G, Bieth N, Schwartz J. Synthesis and beta-adrenergic blocking activity of new aliphatic oxime ethers. J Med Chem 1980;23:620–4.
   PubMed Web of Science ®Google Scholar
• Breschi C, Macchia M, Manera C, et al. Conformationally restrained β-blocking oxime ethers. 3. Synthesis and β-adrenergic antagonistic activity of diastereomeric anti and syn 2-(5′-(3′-methyl)isoxazolidinyl)-N-alkylethanolamines. Eur J Med Chem 1996;31:159–63.
   Web of Science ®Google Scholar
• Xu W, Wang J, Liu C, et al. Experimental and computational studies of the isomerization between Z and E isomers of benzaldoximes. Jnl Chinese Chemical Soc 2004;51:1259–66.
   Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Vullo D, Innocenti A, Nishimori I, et al. Carbonic anhydrase activators: activation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines. Bioorg Med Chem Lett 2007;17:4107–12.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Vullo D, Nishimori I, et al. Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. Bioorg Med Chem 2008;16:3530–6.
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Innocenti A, et al. Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. Bioorg Med Chem Lett 2007;17:1336–40.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, et al. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006;12:7057–66.
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Vullo D, et al. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. J Med Chem 2006;49:3019–27.
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Scozzafava A, et al. Carbonic anhydrase activators: kinetic and x-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV. Bioorg Med Chem 2008;16:8373–837.
   PubMed Web of Science ®Google Scholar
• Saada MC, Vullo D, Montero JL, et al. Carbonic anhydrase I and II activation with mono- and dihalogenated histamine derivatives. Bioorg Med Chem Lett 2011;21:4884–7.
   PubMed Web of Science ®Google Scholar
• Saada MC, Vullo D, Montero JL, et al. Mono- and di-halogenated histamine, histidine and carnosine derivatives are potent carbonic anhydrase I, II, VII, XII and XIV activators. Bioorg Med Chem 2014;22:4752–8.
   PubMed Web of Science ®Google Scholar
• (a) Supuran CT, Dinculescu A, Balaban AT. Carbonic anhydrase activators. Part 5. CA II activation by 2,4,6-trisubstituted pyridinium cations with 1-(ω-aminoalkyl) side chains. Rev Roum Chim 1993;38:343–9.
   Web of Science ®Google Scholar
  (b) Pastorekova S, Casini A, Scozzafava A, et al. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Lett 2004;14:869–73.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Barboiu M, Luca C, et al. Carbonic anhydrase activators. Part 14. Synthesis of mono- and bis- pyridinium salt derivatives of 2-amino-5-(2-aminoethyl)- and 2-amino-5-(3-aminopropyl)-1,3,4-thiadiazole, and their interaction with isozyme II. Eur J Med Chem 1996;31:597–606.
   Web of Science ®Google Scholar
• Scozzafava A, Supuran CT. Carbonic anhydrase activators – part 21. Novel activators of isozymes I, II and IV incorporating carboxamido and ureido histamine moieties. Eur J Med Chem 2000;35:31–9.
   PubMed Web of Science ®Google Scholar
• Briganti F, Scozzafava A, Supuran CT. Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties. Bioorg Med Chem Lett 1999;9:2043–8.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT. Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole. Eur J Pharm Sci 2000;10:29–41.
   PubMed Web of Science ®Google Scholar
• (a) Draghici B, Vullo D, Akocak S, et al. Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect. Chem Commun (Camb) 2014;50:5980–3.
   PubMed Web of Science ®Google Scholar
  (b) Saada MC, Vullo D, Montero JL, et al. Mono- and di-halogenated histamine, histidine and carnosine derivatives are potent carbonic anhydrase I, II, VII, XII and XIV activators. Bioorg Med Chem 2014;22:4752–8.
   PubMed Web of Science ®Google Scholar
• (a) Mollica A, Macedonio G, Stefanucci A, et al. Five- and six-membered nitrogen-containing compounds as selective carbonic anhydrase activators. Molecules 2017;22:2178.
   Web of Science ®Google Scholar
  (b) Maccallini C, Di Matteo M, Vullo D, et al. Indazole, pyrazole, and oxazole derivatives targeting nitric oxide synthases and carbonic anhydrases. ChemMedChem 2016;11:1695–9. 
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT, Scozzafava A. Carbonic anhydrase activators: amino acyl/dipeptidyl histamine derivatives bind with high affinity to isozymes I, II and IV and act as efficient activators. Bioorg Med Chem 1999;7:2915–23.
   PubMed Web of Science ®Google Scholar
• Vistoli G, Aldini G, Fumagalli L, et al. Activation effects of carnosine- and histidine-containing dipeptides on human carbonic anhydrases: a comprehensive study. Int J Mol Sci 2020;21:1761.
   PubMed Web of Science ®Google Scholar
• Akocak S, Lolak N, Bua S, et al. Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives. J Enzyme Inhib Med Chem 2019;34:1193–8.
   PubMed Web of Science ®Google Scholar
• Akocak S, Lolak N, Bua S, et al. α-Carbonic anhydrases are strongly activated by spinaceamine derivatives. Bioorg Med Chem 2019;27:800–4.
   PubMed Web of Science ®Google Scholar
• Chiaramonte N, Maach S, Biliotti C, et al. Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine1. J Enzyme Inhib Med Chem 2020;35:1003–10.
   PubMed Web of Science ®Google Scholar
• Angeli A, Vaiano F, Mari F, et al. Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII. J Enzyme Inhib Med Chem 2017;32:1253–9.
   PubMed Web of Science ®Google Scholar
• Casini A, Caccia S, Scozzafava A, et al. Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II. Bioorg Med Chem Lett 2003;13:2765–8.
   PubMed Web of Science ®Google Scholar
• (a) Abdülkadir Coban T, Beydemir Ş, Gücin İ, et al. Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. Bioorg Med Chem 2009;17:5791–5.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018;33:485–95.
   PubMed Web of Science ®Google Scholar
• Sugimoto A, Ikeda H, Tsukamoto H, et al. Timolol activates the enzyme activities of human carbonic anhydrase I and II. Biol Pharm Bull 2010;33:301–6.
   PubMed Web of Science ®Google Scholar
• (a) Nocentini A, Donald WA, Supuran CT, Human carbonic anhydrases: tissue distribution, physiologic role, and druggability. In: Nocentini A, Supuran CT, eds. Carbonic anhydrases. Amsterdam: Elsevier; 2019. p. 149–185.
   Google Scholar
  (b) Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15:671–86. 
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Liu X, Lu D, Bowser R, et al. Expression of carbonic anhydrase I in motor neurons and alterations in ALS. Int J Mol Sci 2016;17:1820.
   Web of Science ®Google Scholar
• Halmi P, Parkkila S, Honkaniemi J. Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus. Neurochem Int 2006;48:24–30.
   PubMed Web of Science ®Google Scholar
• Svichar N, Chesler M, Waheed A, et al. Carbonic anhydrases CA4 and CA14 both enhance AE3-mediated Cl-HCO3- exchange in hippocampal neurons. J Neurosci 2009;29:3252–8.
   PubMed Web of Science ®Google Scholar
• Ruusuvuori E, Huebner AK, Kirilkin I, et al. Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures. Embo J 2013;32:2275–86.
   PubMed Web of Science ®Google Scholar
• Karjalainen SL, Haapasalo HK, Aspatwar A, et al. Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors. BMC Cancer 2018;18:584.
   PubMed Web of Science ®Google Scholar
• (a) Nocentini A, Alterio V, Bua S, et al. Phenyl(thio)phosphon(amid)ate benzenesulfonamides as potent and selective inhibitors of human carbonic anhydrases II and VII counteract allodynia in a mouse model of oxaliplatin-induced neuropathy. J Med Chem 2020;63:5185–200.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Carbonic anhydrases and metabolism. Metabolites 2018;8:25. 
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12. 
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 2018;28:713–21. 
   PubMed Web of Science ®Google Scholar
  (e) Supuran CT, Altamimi ASA, Carta F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013–2019. Expert Opin Ther Pat 2019;29:781–92.
   PubMed Web of Science ®Google Scholar